Mallinckrodt PLC, an Irish pharmaceutical company with a big footprint and long history in the St. Louis area, will buy U.S.

The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.

ICICI Securities is bullish on Akums Drugs and Pharmaceuticals recommended buy rating on the stock with a target price of Rs ...

Amneal Pharmaceuticals (AMRX) is experiencing significant financial growth by focusing on making generic drugs more affordable and accessible—a ...

New High-Speed Filling Line to Support Growing Demand for Sterile Injectables and Strengthen Domestic Supply Chain- -Learn More About Halo Pharma’s New Sterile Manufacturing Capabilities at DCAT ...

Injectable drugs market is estimated to be valued at USD 614.07 Billion in 2025 and is expected to reach USD 1,032.78 Billion by 2032, CAGR of 7.7% , 2025-2032 BURLINGAME, CA, UNITED STATES, March ...

The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...

This expansion aims to address critical capacity shortages in the US injectable supply chain and meet the growing demand from pharmaceutical companies seeking reliable domestic sterile ...

AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

The FDA has granted orphan drug designation to Plus Therapeutics’ injectable radiotherapy, Rhenium (186Re) Obisbemeda.